Chris Kilbee appointed director of UBM pharma portfolio
This article was originally published in Scrip
Executive Summary
Pharmaceutical event coordinator, CPhI, part of UBM Live, has named Chris Kilbee group director of the UBM pharma portfolio. He will be responsible for strategic development and delivery of market leading event brands CPhI, ICSE, Inno-Pack and P-MEC, held in Europe, China, India, Japan, Russia, Turkey, South America and South-East Asia, and digital solutions including CPhI Online and CPhI Pharma Evolution. Prior to joining the Amsterdam-based firm, Mr Kilbee ran a media and events business based in London.
You may also be interested in...
Six New Molecules By 2030 – J&J’s Neuroscience Strategy
Can neuroscience be precise? Peter Fang, worldwide VP of neuroscience, explains J&J's approach to precision medicine in Alzheimer’s disease, depression and other neurological conditions.
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.